Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.57 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
| ▸ | GABRP | O00591 | 1/20 | 0.45 |
| ▸ | GABRD | O14764 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.45 |
| ▸ | GABRE | P78334 | 1/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.45 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3337353 | 0.86 | GPR3 (0.57) | GPR3KIF11GABRPGABRDGABRA1 | |
| SCHEMBL5070438 | 0.81 | GPR3 (0.55) | GPR3KIF11GABRPGABRDGABRA1 | |
| SCHEMBL27098963 | 0.79 | HSD17B10 (0.37) | GPR3KIF11KDM4EALDH1A1HPGD | |
| SCHEMBL19271289 | 0.78 | KDM4E (0.51) | KDM4EALDH1A1HPGDMAPTHSD17B10 | |
| SCHEMBL20751994 | 0.78 | KDM4E (0.58) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL16621620 | 0.78 | ALKBH5 (0.41) | GPR3GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL23371952 | 0.78 | GPR3 (0.52) | GPR3KIF11GABRPGABRDGABRA1 | |
| SCHEMBL22906722 | 0.77 | NPC1 (0.44) | MAPTNPC1RAB9AATMPOLB | |
| SCHEMBL3423941 | 0.76 | GPR3 (0.80) | GPR3KIF11KDM4EALDH1A1HPGD | |
| SCHEMBL29461528 | 0.76 | GPR3 (1.00) | GPR3KIF11KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10208026-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-02-19 | — | — | US | disclosed |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-24 | — | — | US | disclosed |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-24 | — | — | US | disclosed |
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | KAGOSHIMA UNIVERSITY | 2010-10-07 | — | — | US | disclosed |
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | KAGOSHIMA UNIVERSITY | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | H1-10, MAVS, HNRNPH3 | GPR3 3859/4885KIF11 3687/4885GABRP 3486/4885 |
| US-10208026-B2 | Organic electroluminescent materials and devices | ZYX, LBR, LOXL1 | GPR3 1739/4885KIF11 2333/4885GABRP 3545/4885 |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZYX, LBR, LOXL1 | GPR3 1739/4885KIF11 2333/4885GABRP 3545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.